[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI930236A0 - BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING - Google Patents

BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING

Info

Publication number
FI930236A0
FI930236A0 FI930236A FI930236A FI930236A0 FI 930236 A0 FI930236 A0 FI 930236A0 FI 930236 A FI930236 A FI 930236A FI 930236 A FI930236 A FI 930236A FI 930236 A0 FI930236 A0 FI 930236A0
Authority
FI
Finland
Prior art keywords
foerfarandefoer
bensimidazoler
deras framstaellning
ceiling model
och
Prior art date
Application number
FI930236A
Other languages
Finnish (fi)
Other versions
FI930236A (en
Inventor
Norbert Hauel
Berthold Narr
Uwe Ries
Meel Jacques Van
Wolfgang Wienen
Michael Entzeroth
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4201554A external-priority patent/DE4201554A1/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI930236A0 publication Critical patent/FI930236A0/en
Publication of FI930236A publication Critical patent/FI930236A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Toys (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Instructional Devices (AREA)

Abstract

The invention relates to benzimidazoles of the general formuala <IMAGE> in which R1 to R4 are as defined in Claim 1, and their salts, which have useful properties. The novel compounds are, in particular, angiotensin antagonists.
FI930236A 1992-01-22 1993-01-21 BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING FI930236A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4201554A DE4201554A1 (en) 1992-01-22 1992-01-22 New benzimidazol-1-yl-methyl-bi:phenyl derivs.
DE4219782A DE4219782A1 (en) 1992-01-22 1992-06-17 New benzimidazol-1-yl-methyl-bi:phenyl derivs.
DE4225756A DE4225756A1 (en) 1992-01-22 1992-08-04 Benzimidazoles, medicaments containing these compounds and process for their preparation

Publications (2)

Publication Number Publication Date
FI930236A0 true FI930236A0 (en) 1993-01-21
FI930236A FI930236A (en) 1993-07-23

Family

ID=27203316

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930236A FI930236A (en) 1992-01-22 1993-01-21 BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING

Country Status (18)

Country Link
EP (1) EP0552765B1 (en)
JP (1) JPH05279341A (en)
AT (1) ATE141270T1 (en)
AU (1) AU660209B2 (en)
CA (1) CA2087800A1 (en)
CZ (1) CZ394492A3 (en)
DE (2) DE4225756A1 (en)
DK (1) DK0552765T3 (en)
ES (1) ES2093286T3 (en)
FI (1) FI930236A (en)
GR (1) GR3021303T3 (en)
HU (1) HU217816B (en)
IL (1) IL104485A (en)
MX (1) MX9300306A (en)
NO (1) NO303689B1 (en)
NZ (1) NZ245741A (en)
PL (1) PL172782B1 (en)
SK (1) SK279409B6 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115985A1 (en) * 1993-02-25 1994-08-26 Kohei Nishikawa Vascular hypertrophy suppressor
EP2448575A2 (en) 2009-07-02 2012-05-09 Bilgic Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
EP2377521A1 (en) 2010-03-26 2011-10-19 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of telmisartan and diuretic combination
CN105492439B (en) 2013-06-21 2019-11-22 齐尼思表观遗传学有限公司 Substituted dicyclic compound as bromine structural domain inhibitor
KR102307566B1 (en) 2013-06-21 2021-10-05 제니쓰 에피제네틱스 리미티드 Novel bicyclic bromodomain inhibitors
EP3027604B1 (en) 2013-07-31 2019-02-20 Zenith Epigenetics Ltd. Novel quinazolinones as bromodomain inhibitors
US10710992B2 (en) 2014-12-01 2020-07-14 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
WO2016092375A1 (en) 2014-12-11 2016-06-16 Zenith Epigenetics Corp. Substituted heterocycles as bromodomain inhibitors
EP3233846A4 (en) 2014-12-17 2018-07-18 Zenith Epigenetics Ltd. Inhibitors of bromodomains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928177A1 (en) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K BENZIMIDAZOLE, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
RU1836357C (en) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Benzimidazole derivatives, their isomers, mixtures of isomers, hydrates or their physiologically bearable salts possessing properties antagonistic to angiotenzine
SI9210098B (en) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoles, drugs with this compounds, and process for their preparation

Also Published As

Publication number Publication date
ES2093286T3 (en) 1996-12-16
SK394492A3 (en) 1998-11-04
PL297472A1 (en) 1994-01-24
DE4225756A1 (en) 1994-03-10
DE59303388D1 (en) 1996-09-19
NO303689B1 (en) 1998-08-17
AU3196293A (en) 1993-07-29
CZ394492A3 (en) 1993-11-17
NO930205L (en) 1993-07-23
IL104485A (en) 1999-10-28
SK279409B6 (en) 1998-11-04
HU9300168D0 (en) 1993-04-28
IL104485A0 (en) 1993-05-13
NO930205D0 (en) 1993-01-21
HU217816B (en) 2000-04-28
MX9300306A (en) 1993-07-01
JPH05279341A (en) 1993-10-26
NZ245741A (en) 1995-07-26
AU660209B2 (en) 1995-06-15
GR3021303T3 (en) 1997-01-31
EP0552765B1 (en) 1996-08-14
HUT63626A (en) 1993-09-28
PL172782B1 (en) 1997-11-28
DK0552765T3 (en) 1997-01-13
EP0552765A1 (en) 1993-07-28
FI930236A (en) 1993-07-23
ATE141270T1 (en) 1996-08-15
CA2087800A1 (en) 1993-07-23

Similar Documents

Publication Publication Date Title
FI913503A0 (en) BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI901739A0 (en) BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
SE8406585L (en) benzoic acid
ATE187724T1 (en) AZACHINOXALINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DK0530505T3 (en) hydantoin derivatives
DK0546583T3 (en) Piperidinyl and piperazinylcyclohexanols
PT618190E (en) 9-β-SUBSTITUTED GLYLIC) AMYL (6 SUBSTITUTED) -5-HYDROXY-6-DEOXYETRACYCLINES
IT1270882B (en) FUNGICIDE-BASED OLIGOPEPTIDES
DE69716810D1 (en) 2,3-disubstituted-(5,6) -heteroarylkondensierte-pyrimidin-4-one
FI930236A (en) BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING
MX9603199A (en) Endotheline receptors antagonists.
DK0623620T3 (en) 5-HT 3 pyrrolopyrazinderivater
FI921456A (en) SUBSTITUTES FOR 2 &#39;, 3&#39;-DIDESOXY-5-TRIFLUORMETHYLURIDINE, FORM OF FOUNDATION FOR THE FRAMEWORK OF CHARACTERISTICS
ATE22289T1 (en) N-(3-TRIFLUORMETHYLPHENYL)-N&#39;-PROPARGYLPIPERAZI , ITS PRODUCTION AND USE.
FI960588A0 (en) Thiocarbamoyl compounds for use as microbicides
ATE89555T1 (en) 3-SUBSTITUTED 1-(2-HALOGENALKOXYBENZENESULFONYL)-3-HETEROARYL UREAS.